Literature DB >> 2079073

Does growth hormone influence the severity of phosphopenic rickets?

T Bistritzer1, S A Chalew, A Hanukoglu, K M Armour, P J Haney, A A Kowarski.   

Abstract

The severity of bone disease in phosphopenic rickets is not correlated with serum phosphate levels. In order to determine whether growth hormone (GH) secretion may influence rachitic changes, we evaluated the 24 h integrated concentration of growth hormone (IC-GH) in five children with phosphopenic rickets. Two patients with marked clinical and roentgenographic rachitic abnormalities had normal IC-GH levels. In contrast, three patients with low IC-GH levels had mild rachitic changes. We suggest that the level of spontaneous GH secretion may be one factor which influences the severity of phosphopenic rickets.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079073     DOI: 10.1007/BF01959474

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  Effects of growth hormone therapy on circadian osteocalcin rhythms in idiopathic short stature.

Authors:  M E Markowitz; J DiMartino-Nardi; F Gasparini; K Fishman; J F Rosen; P Saenger
Journal:  J Clin Endocrinol Metab       Date:  1989-08       Impact factor: 5.958

2.  Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25 dihydroxyvitamin D3, phosphate, and ascorbic acid.

Authors:  G H Hirschman; H F DeLuca; J C Chan
Journal:  Pediatrics       Date:  1978-03       Impact factor: 7.124

Review 3.  Renal hypophosphatemic rickets.

Authors:  J C Chan; U Alon; G M Hirschman
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

4.  Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.

Authors:  J C Chan; R D Lovinger; P Mamunes
Journal:  Pediatrics       Date:  1980-09       Impact factor: 7.124

5.  Effect of growth hormone on vitamin D metabolism.

Authors:  E Spanos; D Barrett; I MacIntyre; J W Pike; E F Safilian; M R Haussler
Journal:  Nature       Date:  1978-05-18       Impact factor: 49.962

6.  Surgically curable hypophosphatemic rickets. Diagnosis and management.

Authors:  A Hanukoglu; S A Chalew; C J Sun; H D Dorfman; R W Bright
Journal:  Clin Pediatr (Phila)       Date:  1989-07       Impact factor: 1.168

7.  The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals.

Authors:  Z Zadik; S A Chalew; R J McCarter; M Meistas; A A Kowarski
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

8.  Do short children secrete insufficient growth hormone?

Authors:  Z Zadik; S A Chalew; S Raiti; A A Kowarski
Journal:  Pediatrics       Date:  1985-09       Impact factor: 7.124

9.  Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.

Authors:  R M Harrell; K W Lyles; J M Harrelson; N E Friedman; M K Drezner
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

10.  The effect of treatment on growth and deformity in hypophosphatemic vitamin D-resistant rickets.

Authors:  R D Loeffler; F C Sherman
Journal:  Clin Orthop Relat Res       Date:  1982 Jan-Feb       Impact factor: 4.176

View more
  1 in total

1.  Growth hormone secretion in poorly growing children with renal hypophosphataemic rickets.

Authors:  G Saggese; G I Baroncelli; S Bertelloni; G Perri
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.